CompuMed PE Ratio 2010-2025 | CMPD
Current and historical p/e ratio for CompuMed (CMPD) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. CompuMed PE ratio as of July 29, 2025 is 21.76.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| CompuMed PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-07-28 | 3.70 | 30.83 | |
| 2025-03-31 | 3.80 | $0.12 | 31.67 |
| 2024-12-31 | 3.81 | $0.17 | 22.41 |
| 2024-09-30 | 3.63 | $0.15 | 24.20 |
| 2024-06-30 | 2.06 | $0.11 | 18.73 |
| 2024-03-31 | 1.68 | $0.04 | 42.00 |
| 2023-12-31 | 2.05 | $-0.03 | 0.00 |
| 2023-09-30 | 3.17 | $-0.03 | 0.00 |
| 2023-06-30 | 2.02 | $-0.01 | 0.00 |
| 2023-03-31 | 2.71 | $0.05 | 54.20 |
| 2022-12-31 | 3.10 | $0.07 | 44.29 |
| 2022-09-30 | 4.00 | $0.07 | 57.14 |
| 2022-06-30 | 4.00 | $0.32 | 12.51 |
| 2022-03-31 | 5.50 | $0.50 | 11.00 |
| 2021-12-31 | 7.25 | $0.50 | 14.50 |
| 2021-09-30 | 8.93 | $0.50 | 17.87 |
| 2021-06-30 | 5.37 | $0.25 | 21.47 |
| 2021-03-31 | 6.88 | 0 | 0.00 |
| 2020-12-31 | 6.36 | 0 | 0.00 |
| 2020-09-30 | 5.14 | 0 | 0.00 |
| 2020-06-30 | 4.25 | 0 | 0.00 |
| 2020-03-31 | 6.38 | 0 | 0.00 |
| 2019-12-31 | 8.62 | 0 | 0.00 |
| 2019-09-30 | 4.50 | $0.25 | 17.99 |
| 2019-06-30 | 4.50 | $0.25 | 18.00 |
| 2019-03-31 | 7.00 | $0.25 | 28.00 |
| 2018-12-31 | 2.50 | $0.25 | 10.00 |
| 2018-09-30 | 3.72 | 0 | 0.00 |
| 2018-06-30 | 3.06 | 0 | 0.00 |
| 2018-03-31 | 3.10 | 0 | 0.00 |
| 2017-12-31 | 1.62 | 0 | 0.00 |
| 2017-09-30 | 1.25 | 0 | 0.00 |
| 2017-06-30 | 1.48 | 0 | 0.00 |
| 2017-03-31 | 1.63 | 0 | 0.00 |
| 2016-12-31 | 1.70 | 0 | 0.00 |
| 2010-12-31 | 2.25 | 0 | 0.00 |
| 2010-09-30 | 2.25 | 0 | 0.00 |
| 2010-06-30 | 4.75 | 0 | 0.00 |
| 2010-03-31 | 5.38 | 0 | 0.00 |
| 2009-12-31 | 3.00 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.005B | $0.006B |
| COMPUMED, INC. is a medical systems company engaged primarily in the application of computer technology to medicine. The main aspects of Co.'s business are (i) the licensing of its proprietary technology in the OsteoGramR, a bone density test that was developed by the Company as a means of aiding physicians in diagnosing and monitoring osteoporosis, (ii) the computer interpretation of electrocardiograms, (iii) TeleCor Services Division, which is engaged in transtelephonic cardiac event monitoring. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $222.716B | 26.12 |
| Boston Scientific (BSX) | United States | $157.517B | 37.62 |
| Stryker (SYK) | United States | $152.893B | 31.97 |
| EssilorLuxottica (ESLOY) | France | $140.240B | 0.00 |
| Medtronic (MDT) | Ireland | $118.558B | 16.81 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.586B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.070B | 25.15 |
| ResMed (RMD) | United States | $40.718B | 30.58 |
| GE HealthCare Technologies (GEHC) | United States | $35.587B | 16.90 |
| Agilent Technologies (A) | United States | $34.042B | 22.19 |
| Koninklijke Philips (PHG) | Netherlands | $26.981B | 17.85 |
| Terumo (TRUMY) | Japan | $25.673B | 33.35 |
| Insulet (PODD) | United States | $20.514B | 80.52 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.786B | 12.06 |
| Baxter (BAX) | United States | $14.800B | 11.05 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.840B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.874B | 23.92 |
| Lantheus Holdings (LNTH) | United States | $4.995B | 12.60 |
| Perrigo (PRGO) | Ireland | $3.859B | 9.78 |
| Prestige Consumer Healthcare (PBH) | United States | $3.689B | 16.48 |
| Haemonetics (HAE) | United States | $3.629B | 16.53 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.441B | 28.59 |
| ICU Medical (ICUI) | United States | $3.119B | 23.00 |
| LeMaitre Vascular (LMAT) | United States | $1.863B | 41.64 |
| QuidelOrtho (QDEL) | United States | $1.720B | 11.83 |
| AtriCure (ATRC) | United States | $1.571B | 0.00 |
| Acuren (TIC) | United States | $1.369B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.272B | 28.62 |
| AdaptHealth (AHCO) | United States | $1.259B | 12.78 |
| Phibro Animal Health (PAHC) | United States | $1.135B | 14.51 |
| BioLife Solutions (BLFS) | United States | $1.057B | 0.00 |
| Neogen (NEOG) | United States | $1.048B | 16.66 |
| Curaleaf Holdings (CURLF) | Canada | $0.933B | 0.00 |
| InMode (INMD) | Israel | $0.905B | 9.11 |
| Kestra Medical Technologies (KMTS) | United States | $0.847B | 0.00 |
| Valneva SE (VALN) | France | $0.660B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.632B | 0.00 |
| Evolus (EOLS) | United States | $0.596B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.581B | 0.00 |
| Owens & Minor (OMI) | United States | $0.576B | 4.78 |
| Surmodics (SRDX) | United States | $0.535B | 0.00 |
| CeriBell (CBLL) | United States | $0.533B | 0.00 |
| ZimVie (ZIMV) | United States | $0.524B | 23.81 |
| SNDL (SNDL) | Canada | $0.384B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.322B | 11.83 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.308B | 0.00 |
| Quanterix (QTRX) | United States | $0.304B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.298B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.295B | 0.00 |
| Cerus (CERS) | United States | $0.254B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.250B | 74.00 |
| Biote (BTMD) | United States | $0.249B | 7.00 |
| Viemed Healthcare (VMD) | United States | $0.247B | 20.87 |
| Omeros (OMER) | United States | $0.245B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.245B | 0.00 |
| Brainsway (BWAY) | Israel | $0.224B | 59.15 |
| Sanara MedTech (SMTI) | United States | $0.222B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.217B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.209B | 0.00 |
| Organigram Global (OGI) | Canada | $0.189B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 15.09 |
| Exagen (XGN) | United States | $0.180B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.177B | 0.00 |
| High Tide (HITI) | Canada | $0.175B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.164B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.132B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.123B | 15.18 |
| Jushi Holdings (JUSHF) | United States | $0.107B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.74 |
| Quipt Home Medical (QIPT) | United States | $0.095B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| Safety Shot (SHOT) | United States | $0.081B | 0.00 |
| Zynex (ZYXI) | United States | $0.075B | 0.00 |
| Apyx Medical (APYX) | United States | $0.074B | 0.00 |
| Veru (VERU) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.064B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.92 |
| Nephros (NEPH) | United States | $0.037B | 49.57 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |